Relpax
Product Images NDC 21695-871

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Relpax (NDC 21695-871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (6bb510c8 2ae2 4159 B4c6 0aec5e64b4c9 01)

FDA Label Image

Figure 1 (6bb510c8 2ae2 4159 B4c6 0aec5e64b4c9 02)

FDA Label Image

Figure 2 (6bb510c8 2ae2 4159 B4c6 0aec5e64b4c9 03)

FDA Label Image

Logo (6bb510c8 2ae2 4159 B4c6 0aec5e64b4c9 04)

This is a statement giving information about the distributor of a product, specifically Roerig which is a division of Pfizer Inc. The distribution of this product is done in New York at the given address.*

FDA Label Image

Logo (6bb510c8 2ae2 4159 B4c6 0aec5e64b4c9 05)

This is a description for a distributor called Roerig, which is a division of Pfizer Inc. based in New York, NY 10017.*

FDA Label Image

Relpax 40 mg (6bb510c8 2ae2 4159 B4c6 0aec5e64b4c9 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.